Motus GI Holdings, Inc.

MOTS Healthcare Medical Devices

Motus GI Holdings, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $319,000.00, down 46.1% from fiscal 2022. Operating cash flow growth for three consecutive years.

0.00 0.00 NaN
Market cap
$420.0K
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
2/9
Altman Z
−34.74
Beneish M
n/a
Dividend safety
n/a
Mar '24 Dec '23 Sep '23 Jun '23 Older periods
Piotroski F-Score
3 2 2 3

+8 more TTM periods

ROE
(1,624.82%) (454.34%) 1,601.86% (1,065.40%)
ROA
(166.89%) (103.47%) (106.31%) (100.74%)
ROIC
(1,411.26%) (744,187.50%) (854.19%) (3,005.53%)
Return on Tangible Assets
(482.38%) (369.85%) (414.73%) (244.05%)
Average Days of Receivables
90.41 86.96 102.28 69.59
Free Cash Flow per Share
(0.98) (13.95) (21.55) (30.34)
Free Cash Flow
(8.41) (11.30) (13.49) (15.29)
Capital Expenditures
— (0.10) (0.11) (0.26)
Other line items
Cash ROIC
(81.60%) (113.93%) (108.49%) (88.04%)
Accounts Receivable Turnover
4.92 4.73 2.77 5.95
Accounts Payable Turnover
0.27 0.30 0.36 0.43
Inventory Turnover
1.18 1.55 1.06 1.06
Average Days of Payables
1,340.72 1,181.60 709.67 680.04
Days of Inventory on Hand
204.47 157.16 197.02 206.32
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
754.74% 1,086.83% 1,169.23% 923.74%
Selling, General and Administrative Expense of Revenue
2,148.62% 2,567.40% 2,421.98% 1,871.22%
Share Based Compensation of Revenue
97.86% 147.65% 206.04% 197.48%
Interest Coverage
(15.90) (15.65) (7.03) (7.54)
Operating CF/Net income
0.52 0.87 0.97 0.94
Depreciation/Fixed assets
0.96 0.94 0.94 0.90
Capex/Depreciation
0.00 (0.11) (0.11) (0.24)
Revenue per Share
0.04 0.39 0.58 1.10
Operating CF per Share
(0.98) (13.82) (21.37) (29.82)
Capex per Share
0.00 (0.13) (0.18) (0.52)
Capex to Sales
0.00 0.33 0.31 0.47

Fold the line items

Columns are period end dates